Submit manuscript...
eISSN: 2469-2778

Hematology & Transfusion International Journal

Mini Review Volume 3 Issue 2

Hematospermia: footprint of severe uncontrolled hypertension

Ali Shalizar Jalali

Department of Basic Sciences, Urmia University, Iran

Correspondence: Ali Shalizar Jalali, Histology and Embryology Research Laboratories, Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran, Tel 00984431942593

Received: October 26, 2016 | Published: December 22, 2016

Citation: Jalali AS. Hematospermia: footprint of severe uncontrolled hypertension. Hematol Transfus Int J. 2016;3(2):164. DOI: 10.15406/htij.2016.03.00063

Download PDF

Keywords

hematospermia, oligozoospermia, azoospermia, asthenozoospermia, hematuria

Introduction

Hematospermia, also known as hemospermia, bloody sperm and sanguineous sperm, is a commonly isolated symptom characterized by the presence of glossy visible blood in semen and represents 1% of all andrological and urological symptoms.1 Historical evidences revealed that it had been reported by Hippocrates, Pares, Morgagni, Velpeau, Fournier and Guyon.2,3 It is usually painless but can be seen along with hematuria, frequency, dysuria and scrotal pain as well as infertility.4,5 It has been indicated that hematospermia can result in azoospermia, oligozoospermia and asthenozoospermia leading to male infertility.6,7 Moreover, it often leads to substantial adverse psychological consequences in the patient.8 It was found that 77.50% of men with hematospermia had experienced only one or two episodes prior to visiting urologists.5 The incidence of hematospermia has been reported as one in every 5,000 new patients presenting to urological out-patient clinics. Most men with hematospermia are likely to be less than 40 years old with symptoms ranging from a few weeks to a few months in duration. The likelihood of recurrent hematospermia is seen in the older age group.9

Most often the causes of hematospermia are idiopathic and the precise etiology of this disorder cannot be found in as many as 70 percent of patients.8,9 Based on etiological origins, hematospermia as a mono-symptomatic and/or poly-symptomatic disorder has congenital, inflammatory, infective, traumatic, obstructive, neoplastic, iatrogenic and systemic causes.8,10 Although hematospermia is usually a symptom of urological problems, severe uncontrolled hypertension as a systemic disorder may be the cause.11–13 In line with that, previous studies declared that hypertension can be detected in 7.30% of the patients with hemospermia.14 Based on this concept, since hemospermia treatment depends on the underlying pathological conditions, careful clinical assessments including endorectal magnetic resonance imaging and trans rectal ultrasound15–18 as well as full general examination including blood pressure readings should be carried out to trace the source of hematospermia and establish efficient therapeutic strategies.

Acknowledgements

None.

Conflict of interest

The author declares no conflict of interest.

References

  1. Razek AA, Elhanbly S, Eldeak A. Transrectal ultrasound in patients with hematospermia. J Ultrasound. 2010;13(1):28–33.
  2. Mulhall JP, Albertsen PC. Haemospermia: diagnosis and management. Urology. 1995;46(4):463–467.
  3. Munkel witz R, Krasnokutsky S, Lie J, et al. Current perspectives on hematospermia: a review. J Androl. 1997;18(1):6–14.
  4. Weidner W, Jantos C, Schumacher F, et al. Recurrent haemospermia. Underlying urogenital anomalies and efficacy of imaging procedures. Br J Urol. 1991;67(3):317–323.
  5. Jones DJ. Haemospermia: a prospective study. British Journal of Urology. 1991;67(1):88–90.
  6. Mundy AJ, Ryder TA, Edmonds DK. Asthenozoospermia and the human sperm mid-piece. Hum Reprod. 1995;10(1):116–119.
  7. Singh Iqbal. The sanguineous sperm (hemospermia)-current appraisal and review. Indian Journal of Surgery. 2005;67(6):302–307.
  8. Kumar P, Kapoor S, Nargund V. Haematospermia-a systemic review. Ann R Coll Surg Engl. 2006;88(4):339–342.
  9. Akhter W, Khan F, Chinegwundoh F. Should every patient with hematospermia be investigated? A critical review. Cent European J Urol. 2013;66(1):79–82.
  10. Papp GK, Hoznek A, Hegedüs M, et al. Hematospermia. J Androl. 1994;15:31S–33S.
  11. Hamburger S, Styczynski M, O'Hearne J, et al. Hemospermia and hypertension-two case reports. J Kans Med Soc. 1980;81(10):459–460.
  12. Iversen PS. Hemospermia and hypertension. Ugeskr Laeger. 1987;149(9):596.
  13. Bhaduri S, Riley VC. Haematospermia associated with malignant hypertension. Sex Transm Infect. 1999;75(3):200.
  14. Kochakarn W, Leenanupunth C, Olarn KR, et al. Hemospermia: review of the management with 5 years follow-up. J Med Assoc Thai. 2001;84(11):1518–1521.
  15. Cho IR, Lee MS, Rha KH, et al. Magnetic resonance imaging in hemospermia. J Urol. 1997;157(1):258–262.
  16. Yagci C, Kupeli S, Tok C, et al. Efficacy of transrectal ultrasonography in the evaluation of hematospermia. Clin Imaging. 2004;28(4):286–290.
  17. Jianquan Z. Diagnosis and therapeutics of the causative diseases for hemospermia on transrectal ultrasound. Ultrasound Med Biol. 2006;32:S249.
  18. Prando A. Endorectal magnetic resonance imaging in persistent hemospermia. Int Braz J Urol. 2008;34(2):171–177.
Creative Commons Attribution License

©2016 Jalali. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.